Pre-eclampsia natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
{{CMG}}; {{AE}} {{Ochuko}} | {{CMG}}; {{AE}} {{Ochuko}} | ||
==Natural History, Complications and Prognosis== | ==Natural History, Complications and Prognosis== | ||
*[[ | *[[Preeclampsic]] patients are usually asymptomatic and may deteriorate rapidly without any specific signs and symptoms. <ref name="BrownMagee2018">{{cite journal|last1=Brown|first1=Mark A.|last2=Magee|first2=Laura A.|last3=Kenny|first3=Louise C.|last4=Karumanchi|first4=S. Ananth|last5=McCarthy|first5=Fergus P.|last6=Saito|first6=Shigeru|last7=Hall|first7=David R.|last8=Warren|first8=Charlotte E.|last9=Adoyi|first9=Gloria|last10=Ishaku|first10=Salisu|title=Hypertensive Disorders of Pregnancy|journal=Hypertension|volume=72|issue=1|year=2018|pages=24–43|issn=0194-911X|doi=10.1161/HYPERTENSIONAHA.117.10803}}</ref> | ||
* [[Preeclampsia]] may present the first time intrapartum or early postpartum. | * [[Preeclampsia]] may present the first time intrapartum or early postpartum. | ||
| Line 24: | Line 24: | ||
:* [[Hypothyroidism ]] | :* [[Hypothyroidism ]] | ||
:* [[Impaired memory]] | :* [[Impaired memory]] | ||
*The majority of patients with [disease name] remain asymptomatic for [duration/years]. | |||
*Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3]. | |||
*If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3]. | |||
*Common complications of [disease name] include [complication 1], [complication 2], and [complication 3]. | |||
*Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with [disease name] is approximately [#%]. | |||
==References== | ==References== | ||
Revision as of 19:52, 12 October 2020
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
|
Pre-eclampsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pre-eclampsia natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Pre-eclampsia natural history, complications and prognosis |
|
FDA on Pre-eclampsia natural history, complications and prognosis |
|
CDC on Pre-eclampsia natural history, complications and prognosis |
|
Pre-eclampsia natural history, complications and prognosis in the news |
|
Blogs on Pre-eclampsia natural history, complications and prognosis |
|
Risk calculators and risk factors for Pre-eclampsia natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Natural History, Complications and Prognosis
- Preeclampsic patients are usually asymptomatic and may deteriorate rapidly without any specific signs and symptoms. [1]
- Preeclampsia may present the first time intrapartum or early postpartum.
- Common complications of preeclampsia include:
- Long term complication of preeclampsia include:[2]
- The majority of patients with [disease name] remain asymptomatic for [duration/years].
- Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
- If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
- Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
- Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with [disease name] is approximately [#%].
References
- ↑ Brown, Mark A.; Magee, Laura A.; Kenny, Louise C.; Karumanchi, S. Ananth; McCarthy, Fergus P.; Saito, Shigeru; Hall, David R.; Warren, Charlotte E.; Adoyi, Gloria; Ishaku, Salisu (2018). "Hypertensive Disorders of Pregnancy". Hypertension. 72 (1): 24–43. doi:10.1161/HYPERTENSIONAHA.117.10803. ISSN 0194-911X.
- ↑ Williams, David (2011). "Long-Term Complications of Preeclampsia". Seminars in Nephrology. 31 (1): 111–122. doi:10.1016/j.semnephrol.2010.10.010. ISSN 0270-9295.